SUNITA PUDASAINI: Open Payments
NPI 1902255532 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,891 in 185 payments from 22 companies in 2025. Trend: 2023 $1,319 · 2024 $3,382 · 2025 $3,891
Food & beverage: $3,734Education: $157
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 42 | $1,055 |
| ABBVIE INC. | 19 | $447 |
| Amgen Inc. | 23 | $420 |
| UCB, Inc. | 10 | $331 |
| PFIZER INC. | 15 | $237 |
| E.R. Squibb & Sons, L.L.C. | 23 | $208 |
| Novartis Pharmaceuticals Corporation | 9 | $202 |
| GENZYME CORPORATION | 11 | $150 |
| Actelion Pharmaceuticals US, Inc. | 2 | $126 |
| ANI Pharmaceuticals, Inc. | 4 | $103 |
Products named: TREMFYA, RINVOQ, Bimzelx, ORENCIA, OTEZLA, KRYSTEXXA, XELJANZ, COSENTYX.
Industry payments across CO — which companies pay providers there.
